-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
January 01, 2025 - NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR 50% pain reduction, Neuropathic Pain Symptom … cannabidivarin
CBN cannabinol
CI confidence interval
CRS category rating scale
ESAS Edmonton Symptom … Questionnaire
NA not applicable
NPP neuropathic pain
NPS Neuropathic Pain Scale
NPSI-T Neuropathic Pain Symptom
-
effectivehealthcare.ahrq.gov/health-topics/gastrointestinal-bleeding
-
effectivehealthcare.ahrq.gov/health-topics/bladder-cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
March 01, 2012 - Evidence-Based
Practice
Evidence-based Practice
Program
The Agency for Healthcare Research and
Quality (AHRQ), through its Evidence-
based Practice Centers (EPCs), sponsors
the development of evidence reports and
technology assessments to assist public-
and private-sector organizations in their
efforts to imp…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults
Making Healthcare Safer IV
Deprescribing To Reduce Medication
Harms in Older Adults
Rapid Response
Main Points
• Deprescribing has emerged as a clinical practice to reduce polypharmacy and
use of potenti…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/smoking-pregnancy-infants_research-protocol.pdf
March 11, 2013 - Source: www.effectivehealthcare.ahrq.gov
Published online: March 11, 2013
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Smoking Cessation Interventions During Pregnancy and the Postpartum Period
I. Background and Objectives for the Systematic Review
Nearly 443,000 U.S. deaths…
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
June 02, 2011 - ASSESSING THE QUALITY OF INCLUDED STUDIES
6/09/11 1
Assessing the Risk of Bias of Individual Studies when
Comparing Medical Interventions
Introduction
In this document, we update existing AHRQ guidance for systematic reviews on assessment
of risk of bias of individual studies. As with other AHRQ method…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
May 01, 2012 - DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores
Research from the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network
May 2012
Effective Health Care Program
Research Reports
Number 33
Summary Variables in Observational Research:
Prop…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/candor/psml-planning-grants-final-report.pdf
May 01, 2016 - Planning Grants Final Evaluation Report: Longitudinal Evaluation of the PSML Reform Demonstration Program
Longitudinal Evaluation of the Patient Safety and
Medical Liability Reform Demonstration Program
Planning Grants Final Evaluation Report
Longitudinal Evaluation of the Patient Safety and
Medical Liability Re…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
May 02, 2023 - If screening test results for LTBI are positive, a medical and social history, symptom assessment, physical
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp3.pdf
March 01, 2009 - Nutrition Research Series: Volume 3: Reporting of Systematic Reviews of Micronutrients and Health: A Critical Appraisa
Technical Review #17
Nutrition Research Series
Volume 3: Reporting of Systematic Reviews of Micronutrients …
-
www.ahrq.gov/sites/default/files/publications/files/psml-planning-grants-final-report.pdf
May 01, 2016 - Planning Grants Final Evaluation Report: Longitudinal Evaluation of the PSML Reform Demonstration Program
Longitudinal Evaluation of the Patient Safety and
Medical Liability Reform Demonstration Program
Planning Grants Final Evaluation Report
Longitudinal Evaluation of the Patient Safety and
Medical Liability Re…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening-december-2013
July 30, 2013 - Comparison between screen-detected and symptom-detected cases.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_disposition-comments.pdf
September 10, 2014 - Disposition of Comments Report for Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Core Needle and Open Surgical Biopsy for Diagnosis of Breast
Lesions: An Update to th…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - 1
Comparative Effectiveness Review
Number 168
Diagnosis and Management of Infantile
Hemangioma
Executive Summary
Introduction
Infantile hemangiomas (IH) are the most
common tumors of childhood. IH are
benign but possess potential for local
tissue damage, ulceration, infection,
bleeding, functional impact, and…
-
digital.ahrq.gov/sites/default/files/docs/page/ahrq-health-information-technology-portfolio-2012-annual-report.pdf
January 01, 2012 - Symptom Monitoring and Reporting System for Pediatric
Chronic Illness PAR-HS-08-269
No Lakshminarayan
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
November 13, 2016 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medica…
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2021.pdf
January 01, 2021 - NASS Summary Statistics 2021 16:25 Wednesday, February 14, 2024 1
DX_PR_GRPS File Contents: weighted
Alphabetic List of Variables and Attributes
Num Variable Type Len Pos Label
548 CMR_AIDS Num 3 1638 Acquired immune deficiency syndrome
549 CMR_ALCOHOL Num 3 1641 Alcohol abuse
550 CMR_AUTOIMMUNE Num 3 1644 Autoimm…
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2021.pdf
January 01, 2021 - NASS Summary Statistics 2021 16:25 Wednesday, February 14, 2024 1
DX_PR_GRPS File Contents
Alphabetic List of Variables and Attributes
Num Variable Type Len Pos Label
548 CMR_AIDS Num 3 1638 Acquired immune deficiency syndrome
549 CMR_ALCOHOL Num 3 1641 Alcohol abuse
550 CMR_AUTOIMMUNE Num 3 1644 Autoimmune condit…
-
hcup-us.ahrq.gov/db/nation/nass/stats/NASS_Summary_Stats_DX_PR_GRPS_Weighted_2022.pdf
January 01, 2022 - NASS Summary Statistics 2022 14:04 Monday, November 11, 2024 1
DX_PR_GRPS File Contents
Alphabetic List of Variables and Attributes
Num Variable Type Len Pos Label
3 CMR_AIDS Num 3 9 Acquired immune deficiency syndrome
4 CMR_ALCOHOL Num 3 12 Alcohol abuse
5 CMR_AUTOIMMUNE Num 3 15 Autoimmune conditions
6 CMR_CANC…